|
Name
|
Auflagedatum
|
Volumen
|
YTD-P
|
1-Y-P
|
3-Y-P
|
5-Y-P
|
|
Galileo - Biotech Innovation Fund
LU2226244361
USD / Acc. / Retail
|
31.03.2021
5,3 Jahre
|
46,59 |
+25,73% |
+80,99% |
+14,79% |
-52,52% |
|
JPMorgan Funds - Thematics - Genetic Therapies Fund
LU2050612402
USD / Acc. / Retail
|
24.10.2019
6,8 Jahre
|
354,68 |
+17,62% |
+56,04% |
+19,19% |
-24,24% |
|
Abaris Biotechnology Opportunities
LU2210105313
USD / Acc. / Retail
|
30.10.2020
5,7 Jahre
|
8,04 |
+18,08% |
+82,48% |
+101,97% |
-0,76% |
|
PPF ("PMG Partners Funds") - Helix Biotechnology Fund
LU1230343250
USD / Acc. / Retail
|
21.10.2015
10,8 Jahre
|
35,34 |
+31,26% |
+93,36% |
+61,61% |
+4,96% |
|
Protea Fund - Sectoral Biotech Opportunities Fund
LU1176840327
USD / Acc. / Retail
|
27.02.2015
11,4 Jahre
|
26,52 |
+9,99% |
+52,76% |
+37,64% |
+14,77% |
|
L&G Pharma Breakthrough UCITS ETF
IE00BF0H7608
USD / Acc. / Retail
|
18.01.2018
8,5 Jahre
|
17,90 |
+12,40% |
+45,00% |
+31,83% |
+17,33% |
|
RH&PARTNER Investment Funds - RH&P Global Life Sciences Fund
LU0115986761
USD / Acc. / Retail
|
06.09.2000
25,9 Jahre
|
65,99 |
+15,23% |
+42,47% |
+34,78% |
+18,69% |
|
Allianz Biotechnologie
DE0008481862
EUR / Dist. / Retail
|
09.01.1998
28,6 Jahre
|
287,17 |
+12,48% |
+49,62% |
+35,99% |
+25,04% |
|
Aescap Life Sciences
NL0012343958
EUR / Acc. / Retail
|
29.03.2016
10,3 Jahre
|
144,33 |
+14,46% |
+82,72% |
+75,69% |
+25,19% |
|
UBS (Lux) Equity Fund - Biotech (USD)
LU0069152568
USD / Acc. / Retail
|
15.10.1996
29,8 Jahre
|
450,23 |
+19,91% |
+62,56% |
+47,33% |
+28,75% |